Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Evaluation of Pepsinogen I as a Biomarker of Drug-induced Gastric Mucosal Injury in Cynomolgus Monkeys.

Ennulat D, Lynch KM, Kimbrough CL, Mirabile RC, Rehm S.

Toxicol Pathol. 2017 Feb;45(2):296-301. doi: 10.1177/0192623316678696. Epub 2016 Dec 22.

PMID:
28007014
2.

Alveolar Macrophage Distribution in a Mouse Model: The Importance of the Fixation Method.

Wheeldon EB, Podolin PL, Mirabile RC.

Toxicol Pathol. 2015 Dec;43(8):1162-5. doi: 10.1177/0192623315600276. Epub 2015 Sep 8.

PMID:
26353977
3.

Species-specific inflammatory responses as a primary component for the development of glomerular lesions in mice and monkeys following chronic administration of a second-generation antisense oligonucleotide.

Frazier KS, Sobry C, Derr V, Adams MJ, Besten CD, De Kimpe S, Francis I, Gales TL, Haworth R, Maguire SR, Mirabile RC, Mullins D, Palate B, Doorten YP, Ridings JE, Scicchitano MS, Silvano J, Woodfine J.

Toxicol Pathol. 2014 Jul;42(5):923-35. doi: 10.1177/0192623313505781. Epub 2013 Nov 28.

PMID:
24292388
4.

MicroRNA changes in rat mesentery and serum associated with drug-induced vascular injury.

Thomas RA, Scicchitano MS, Mirabile RC, Chau NT, Frazier KS, Thomas HC.

Toxicol Appl Pharmacol. 2012 Aug 1;262(3):310-20. doi: 10.1016/j.taap.2012.05.009. Epub 2012 May 22.

PMID:
22627061
5.

In vivo serial assessment of aortic aneurysm formation in apolipoprotein E-deficient mice via MRI.

Turner GH, Olzinski AR, Bernard RE, Aravindhan K, Karr HW, Mirabile RC, Willette RN, Gough PJ, Jucker BM.

Circ Cardiovasc Imaging. 2008 Nov;1(3):220-6. doi: 10.1161/CIRCIMAGING.108.787358. Epub 2008 Sep 17.

PMID:
19808546
6.

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development.

Wilensky RL, Shi Y, Mohler ER 3rd, Hamamdzic D, Burgert ME, Li J, Postle A, Fenning RS, Bollinger JG, Hoffman BE, Pelchovitz DJ, Yang J, Mirabile RC, Webb CL, Zhang L, Zhang P, Gelb MH, Walker MC, Zalewski A, Macphee CH.

Nat Med. 2008 Oct;14(10):1059-66. doi: 10.1038/nm.1870. Epub 2008 Sep 21.

7.

Transcriptional profiling of laser capture microdissected rat arterial elements: fenoldopam-induced vascular toxicity as a model system.

Dalmas DA, Scicchitano MS, Chen Y, Kane J, Mirabile R, Schwartz LW, Thomas HC, Boyce RW.

Toxicol Pathol. 2008 Apr;36(3):496-519. doi: 10.1177/0192623307311400. Epub 2008 May 8.

PMID:
18467687
8.

Evaluation of the cynomolgus monkey stomach: recommendations for standard sampling procedures in nonclinical safety studies.

Vidal JD, Mirabile RC, Thomas HC.

Toxicol Pathol. 2008 Feb;36(2):250-5. doi: 10.1177/0192623307312700. Epub 2008 Mar 25.

PMID:
18364462
9.

p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment.

Morris JB, Olzinski AR, Bernard RE, Aravindhan K, Mirabile RC, Boyce R, Willette RN, Jucker BM.

Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):265-71. Epub 2007 Dec 27.

PMID:
18162612
10.

Novel vascular lesions in mice given a non-peptide vitronectin receptor antagonist.

Rehm S, Thomas RA, Smith KS, Mirabile RC, Gales TL, Eustis SL, Boyce RW.

Toxicol Pathol. 2007 Dec;35(7):958-71.

PMID:
18098042
11.

Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.

Bao W, Behm DJ, Nerurkar SS, Ao Z, Bentley R, Mirabile RC, Johns DG, Woods TN, Doe CP, Coatney RW, Ohlstein JF, Douglas SA, Willette RN, Yue TL.

J Cardiovasc Pharmacol. 2007 Jun;49(6):362-8.

PMID:
17577100
12.

P38 MAPK inhibitors suppress biomarkers of hypertension end-organ damage, osteopontin and plasminogen activator inhibitor-1.

Nerurkar SS, Olzinski AR, Frazier KS, Mirabile RC, O'Brien SP, Jing J, Rajagopalan D, Yue TL, Willette RN.

Biomarkers. 2007 Jan-Feb;12(1):87-112.

PMID:
17438656
13.

Inhibition of ALK5 signaling induces physeal dysplasia in rats.

Frazier K, Thomas R, Scicchitano M, Mirabile R, Boyce R, Zimmerman D, Grygielko E, Nold J, DeGouville AC, Huet S, Laping N, Gellibert F.

Toxicol Pathol. 2007 Feb;35(2):284-95.

PMID:
17366323
14.

Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection.

Olzinski AR, McCafferty TA, Zhao SQ, Behm DJ, Eybye ME, Maniscalco K, Bentley R, Frazier KS, Milliner CM, Mirabile RC, Coatney RW, Willette RN.

Cardiovasc Res. 2005 Apr 1;66(1):170-8. Epub 2005 Jan 28.

PMID:
15769460
15.
16.

SB-236057: Critical window of sensitivity study and embryopathy of a potent musculoskeletal teratogen.

Augustine-Rauch KA, Zhang QJ, Posobiec L, Mirabile R, DeBoer LS, Solomon HM, Wier PJ.

Birth Defects Res A Clin Mol Teratol. 2004 Oct;70(10):773-88.

PMID:
15472921
17.

Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys.

Hoivik DJ, Qualls CW Jr, Mirabile RC, Cariello NF, Kimbrough CL, Colton HM, Anderson SP, Santostefano MJ, Morgan RJ, Dahl RR, Brown AR, Zhao Z, Mudd PN Jr, Oliver WB Jr, Brown HR, Miller RT.

Carcinogenesis. 2004 Sep;25(9):1757-69. Epub 2004 May 6.

PMID:
15131011
18.

Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury.

Bao W, Hu E, Tao L, Boyce R, Mirabile R, Thudium DT, Ma XL, Willette RN, Yue TL.

Cardiovasc Res. 2004 Feb 15;61(3):548-58.

PMID:
14962485
19.

p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging.

Lenhard SC, Nerurkar SS, Schaeffer TR, Mirabile RC, Boyce RW, Adams DF, Jucker BM, Willette RN.

J Pharmacol Exp Ther. 2003 Dec;307(3):939-46. Epub 2003 Oct 15.

PMID:
14561850
20.

Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury.

Yue TL, Bao W, Jucker BM, Gu JL, Romanic AM, Brown PJ, Cui J, Thudium DT, Boyce R, Burns-Kurtis CL, Mirabile RC, Aravindhan K, Ohlstein EH.

Circulation. 2003 Nov 11;108(19):2393-9. Epub 2003 Oct 13.

PMID:
14557369
21.

Cloning, expression, and initial characterization of a novel cytokine-like gene family.

Zhu Y, Xu G, Patel A, McLaughlin MM, Silverman C, Knecht K, Sweitzer S, Li X, McDonnell P, Mirabile R, Zimmerman D, Boyce R, Tierney LA, Hu E, Livi GP, Wolf B, Abdel-Meguid SS, Rose GD, Aurora R, Hensley P, Briggs M, Young PR.

Genomics. 2002 Aug;80(2):144-50.

PMID:
12160727
22.

Sustained activation of p38 mitogen-activated protein kinase contributes to the vascular response to injury.

Ju H, Nerurkar S, Sauermelch CF, Olzinski AR, Mirabile R, Zimmerman D, Lee JC, Adams J, Sisko J, Berova M, Willette RN.

J Pharmacol Exp Ther. 2002 Apr;301(1):15-20.

PMID:
11907152
23.

Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy.

Yue TL, Gu JL, Wang C, Reith AD, Lee JC, Mirabile RC, Kreutz R, Wang Y, Maleeff B, Parsons AA, Ohlstein EH.

J Biol Chem. 2000 Dec 1;275(48):37895-901.

24.

Identifying the employee of the future.

Mirabile RJ.

J Bus Strategy. 1991 May-Jun;12(3):32-6.

PMID:
10111374
25.

Staphylococcal scalded-skin syndrome.

Mirabile R, Weiser M, Barot LR, Brown AS.

Plast Reconstr Surg. 1986 May;77(5):752-6.

PMID:
3703998
26.

Giant-cell granuloma of the jaw.

Mirabile R, Brown AS, Gisser S.

Plast Reconstr Surg. 1986 Mar;77(3):479-81.

PMID:
3952205
27.

A model for competency-based career development.

Mirabile RJ.

Personnel. 1985 Apr;62(4):30-8. No abstract available.

PMID:
10272901

Supplemental Content

Loading ...
Support Center